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Neuroprotective effects and autophage of
Wonji-Gobon Mixture (WGM) in a Parkinson’s
disease mouse model
Taek-Won Ahn
Department of Sasang Constitutional Medicine,
College of Korean Medicine, Daejeon University
Purpose: Purpose: To evaluate the autophage and neuro-
protective effects of WGM, a Chinese traditional medicinal
prescription in a Parkinson’s disease mouse model.
Methods: Methods: Cell viability was measuredcusing a
LHD-release assay and MTT assay. To ﬁnd out the autophagy-
relative mRNA gene expression in BV2 microglia cell line,
LC3, LC3a, LC3b, Beclin-1, ATG5 were examined by RT-PCR.
To ﬁnd out the autophagy-relative protein expression of sig-
nal events in BV2 microglia cell line, LC3b-1, LC3b-II, Beclin1
were examined by western blotting. To ﬁnd out the autophagy
detection in BV2 microglia cell line. Cells were assayed for
autophagy positive cells by FACS analysis. To measure the
amount of dopamine in mice brain, ST-SNpc were exam-
ined by Bradford. Immunohistochemistry was examined in
the MPTP-induced Parkinson’s disease mice to evaluate the
neuroprotective effects of WGM on ST and SNpc. Ischemic
mice brain stainedwith TTC in theMPTP- induced Parkinson’s
disease to ﬁnd out ischemia in mouse In order to investigate
the effect of WGM on recovery of memory, we examined the
memory by usingMorris watermaze test. Immunohistochem-
istry was examined in the MPTP-induced Parkinson’s disease
mice to evaluate the neuroprotective effects of WGM on hip-
pocampal lesion. In order to investigate the effect of WGM on
recovery of behavioral deﬁcits, we examined the motor func-
tion by using and FST. The convenient, simple, and accurate
HPLC method was established for simultaneous determina-
tion of Neurotransmitters in MPTP-WGM group.
Results: Results and Conclusion: WGM can enhance the
induction of autophagy through key regulator beclin1 and
LC3b-II. WGM inhalation in MPTP mice led to the restoration
of behavioral impairment and rescued dopamine, TH-IR cell,
hippocampus, serotonin. Furthermore,WGMessential oilmay
serve as a potential preventive or therapeutic agent regarding
Parkinson’s disease.
Conclusion: Acknowledgement: This research was sup-
ported by Basic Science Research Program through the NRF
funded by the Ministry of Education, Science and Technol-
ogy(201401850001)
Contact: Taek-Won Ahn, twahn@dju.kr
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In vitro study for exploring anti-obesity agent
using the extracts from Centella spp. of
Australia
JunLae Cho1, Ali Alqahtani2, George Qian Li2
1 Faculty of Pharmacy, University of Sydney /
Sydney Institute of Traditional Chinese Medicine
2 Faculty of Pharmacy, University of Sydney
Purpose: The genous Centella comprises several varieties
and species, and has important medicinal beneﬁts. In pre-
vious study, we reported the genus Centella from Australia
reveal obvious different varieties in terms of phytochemi-
cal compositions and antioxidant efﬁcacies, and even the
genetics. Obesity is the well-known risk factor to induce
diabetes mellitus and its complications, including cardiovas-
cular disease. The aim of this study is to investigate the
pharmaco-therapeutic efﬁcacy of Australian populations of
Centella species as an anti-obesity agent and to evaluate the
effect of their adaptation in vitro.
Methods: Adipocytes were prepared using 25mM of high
glucose culturing medium. Lipid droplet deposition in the
adipocyte was evaluated using Oil-Red-O staining. Quanti-
tative polymerase chain reaction (qRT-PCR) was performed
in order to assess post-transcriptional activation or inhi-
bition of adiponectin, Glut-4, Tribble family proteins (Trib),
and C1q/TNF- related proteins (CTRP). Immunoblotting also
adopted to identify the post-translational activation of Glut-4,
Trib3 and CTRP6. Ant-Advanced glycation endproducts (AGEs)
function was evaluated using AGE-BSA binding assay.
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Results: The treatment of Centella spp. revealed signiﬁcant
reduction of lipid droplet deposition anddecrease of the size of
lipid droplet in the adipocyte. Molecular biological experiment
suggested that the treatment of Centella spp. signiﬁcantly
inhibited the expression of Trib 3: more than 100% of Trib3
was decreased compared to the control. On the contrary, the
express ion of adiponectin, CTRP 6 and Glut 4 were consider-
ably increased by the treatment of these herbal extracts.
Conclusion: These results suggest that the adaptation of
these herbal extracts have signiﬁcant potential to inhibit fatal
etiological triggering of cardiovascular disease causing by the
obesity. Hence, these herbal extract might be a therapeutic
target to ﬁght against obesity and its associated diseases in
modern industrial countries.
Contact: JunLae Cho, junlae.cho@sydney.edu.au
http://dx.doi.org/10.1016/j.imr.2015.04.284
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Experimental Study on Protective and
Anti-obesity Effects of Inulin from Chicory
(Cichorium intybus L.) on Quail Model
Zhijian LIN, Bing ZHANG ∗, Liyu LI,
Hongpo WANG, Chunsheng ZHU
School of Chinese Pharmacy, Beijing University of
Chinese Medicine
Purpose: Inulin from Cichorium intybus L., a kind of Chi-
nese Materia Medica, is potential therapeutics that act alone
or supplement on serummetabolic parameters in the preven-
tion and treatment of obesity. The present investigation was
undertaken to study the protective and anti-obesity effects of
inulin from Cichorium intybus L. on serum lipid concentra-
tion and abdominal fat pad mass in quail model induced by
protein and purine rich diet.
Methods: Quails were divided randomly into 5 groups
according to bodyweight: normal group,model group, positive
control group and chicory inulin high and low dosage groups.
The normal group was fed with the common feedstuff, and
the other groups were fed with protein and purine rich diet.
Positive control group was given Fenoﬁbrate 100mg/ (kg•d).
Chicory inulin groups were given inulin 10, 5 g/(kg•d) respec-
tively. All quails were given distilled water. Serum triglyceride
(TG), abdominal fat pad mass and acetyl-Coa carboxlyase
(ACC), fatty acid synthase (FAS) activity were determined.
Results: Compared with normal group serum TG level of
model group was signiﬁcantly higher on 21d and 28d and
abdominal fat pad mass increased on 28d. Compared with
model, fenoﬁbrate decreased serum TG level on 21d and 28d.
Chicory inulin decreased TG signiﬁcantly and abdominal fat
pad mass on 28d. ACC protein expression and fatty acid syn-
thase (FAS) activities were decreased in chicory inulin groups
signiﬁcantly. However, serum cholesterol (TC), low-density
lipoprotein (LDL) andhigh-density lipoprotein (HDL) levelwere
not signiﬁcantly altered by treatment.
Conclusion: Inulin of Cichorium intybus L. signiﬁcantly
improved lipid metabolism of diet induced abdominal obe-
sity in quails. The possible mechanism of anti-obesity activity
appears to be either decreasing ACC protein expression and
FAS activity, or decreasing serum TG level property.
Contact: Zhijian LIN, linzhijian83@126.com
Corresponding author: Bing ZHANG (School of Chi-




Aqueous extract of solanum nigrum
activated programmed cell death and
enhanced cisplatin/doxorubicin induced
cytotoxicity on human hepatocellular carc
Chien-Kai Wang, Cheng-Jeng Tai, Chen-Jei Tai
Taipei Medical University Hospital
Purpose: In traditional Chinese medicine, the aqueous
extract of solanum nigrum (AESN) is a key ingredient pre-
sented in various formulas for dealing with cancer patients.
Recent studies suggested AESN is capable of activating pro-
grammed cell death inmany human cancer types both in vitro
and in vivo. This study is to examine the antitumor potential
of AESN in integrationwith standard chemotherapeutic drugs,
cisplatin and doxorubicin, on human hepatocellular cancer
cells.
Methods: Human hepatocellular carcinoma cells, Hep3B
and HepJ5, were treated by 0 to 10mg/ml AESN for 48 hr to
determine the cytotoxicity. Hep3B andHepJ5 cellswere treated
with 0, 0.5 or 1.0mg/ml AESN with 0 to 20M cisplatin or 0
to 10M doxorubicin respectively for 48 hr to evaluate the
combined cytotoxic effects. The activation of programmed cell
deathmarkers, caspase-3 and caspase-7 for apoptosis and LC3
A/B for autophagy were also determined by western blotting
assay on AESN-treated cells.
Results: The half-maximum inhibitory concentrations
(IC50s) of AESN on Hep3B and HepJ5 cells were 0.96 and
0.97mg/ml respectively. The co-treatment of AESN (0.5mg/ml)
reduced the IC50s of cisplatin from 6.75 to 2.75M on Hep3B
cells and 8.71 to 2.84M on HepJ5 cells, whereas the IC50s
of doxorubicin were reduced from 4.65 to 1.31M on Hep3B c
ells, and 6.39 to 1.42MonHepJ5 cells. AESN induced the accu-
mulation of LC3 A/B II and the cleavage of caspase-7 but not
caspase-3 on Hep3B and HepJ5 cells suggested the induction
of autophagic and apoptotic cell death by AESN.
Conclusion: This study indicated that AESN activated pro-
grammed cell death including caspase-7 related apoptosis and
autophagy to enhance cytotoxicity induced by cisplatin and
doxorubicin in human hepatocellar carcinoma cells. These
experimental evidences suggested AESN is a potential ingre-
dient to develop the novel integrated chemotherapy with
cisplatin or doxorubicin on treating hepatocellular carcinoma.
Contact: Chien-Kai Wang, wchienkai@tmu.edu.tw
http://dx.doi.org/10.1016/j.imr.2015.04.286
